The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
ISA 2022 | Comparison of current cardiac staging systems in AL amyloidosis
Tobias Dittrich, MD, Heidelberg University, Heidelberg, Germany, compares and contrasts the different available cardiac staging systems in the field of AL amyloidosis. Dr Dittrich explains that overall, these staging systems are comparable and can accurately stratify patients with AL amyloidosis. This interview took place at the 2022 International Symposium on Amyloidosis (ISA) held in Heidelberg, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
